NEW YORK, Nov. 2, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to SouthState Corporation. Subject to the terms of the merger agreement, Atlantic Capital shareholders will receive 0.36 shares of SouthState common stock for each outstanding share of Atlantic Capital common stock. If you are an Atlantic Capital shareholder, click here to learn more about your rights and options.
Triple-S Management Corporation (NYSE: GTS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to GuideWell Mutual Holding Corporation for $36.00 per share in cash. If you are a Triple-S Management shareholder, click here to learn more about your rights and options.
ADTRAN, Inc. (NASDAQ: ADTN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with ADVA. Following completion of the transaction, ADTRAN shareholders are expected to own approximately 54% of the combined company. If you are an ADTRAN shareholder, click here to learn more about your rights and options.
Columbia Banking System, Inc. (NASDAQ: COLB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Umpqua Holdings Corporation. Under the terms of the agreement, Umpqua shareholders will receive 0.5958 of a share of Columbia stock for each Umpqua share they own. Upon completion of the transaction, Columbia shareholders will own approximately 38% of the combined company. If you are a Columbia shareholder, click here to learn more about your rights and options.
DSP Group, Inc. (NASDAQ: DSPG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Synaptics Incorporated for $22.00 per share in cash. If you are a DSP Group shareholder, click here to learn more about your rights and options.
Flexion Therapeutics, Inc. (NASDAQ: FLXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pacira BioSciences, Inc. for $8.50 per share in cash plus one non-tradeable contingent value right worth up to $8.00 per share in cash. If you are a Flexion shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE Halper Sadeh LLP
Share this article